vs
Abacus Global Management, Inc.（ABX）与PUMA BIOTECHNOLOGY, INC.（PBYI）财务数据对比。点击上方公司名可切换其他公司
PUMA BIOTECHNOLOGY, INC.的季度营收约是Abacus Global Management, Inc.的1.0倍（$75.5M vs $71.9M），Abacus Global Management, Inc.同比增速更快（116.5% vs 27.7%），PUMA BIOTECHNOLOGY, INC.自由现金流更多（$14.4M vs $-26.6M），过去两年Abacus Global Management, Inc.的营收复合增速更高（82.9% vs 31.3%）
Abacus集团是澳大利亚ASX 200指数成分公众上市公司，专注投资澳大利亚房地产投资信托，投资组合集中在写字楼与自助仓储领域，同时管理房地产开发的legacy投资项目。该公司原名为Abacus地产集团，2023年8月拆分出了自助仓储业务Abacus Storage King。
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
ABX vs PBYI — 直观对比
营收规模更大
PBYI
是对方的1.0倍
$71.9M
营收增速更快
ABX
高出88.8%
27.7%
自由现金流更多
PBYI
多$41.0M
$-26.6M
两年增速更快
ABX
近两年复合增速
31.3%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $71.9M | $75.5M |
| 净利润 | $7.2M | — |
| 毛利率 | 88.8% | 69.3% |
| 营业利润率 | 31.7% | 22.7% |
| 净利率 | 10.1% | — |
| 营收同比 | 116.5% | 27.7% |
| 净利润同比 | 139.6% | — |
| 每股收益（稀释后） | $0.06 | $0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ABXPBYI
| Q4 25 | $71.9M | $75.5M | ||
| Q3 25 | $63.0M | $54.5M | ||
| Q2 25 | $56.2M | $52.4M | ||
| Q1 25 | $44.1M | $46.0M | ||
| Q4 24 | $33.2M | $59.1M | ||
| Q3 24 | $28.1M | $80.5M | ||
| Q2 24 | $29.1M | $47.1M | ||
| Q1 24 | $21.5M | $43.8M |
净利润ABXPBYI
| Q4 25 | $7.2M | — | ||
| Q3 25 | $7.1M | $8.8M | ||
| Q2 25 | $17.6M | $5.9M | ||
| Q1 25 | $4.6M | $3.0M | ||
| Q4 24 | $-18.3M | — | ||
| Q3 24 | $-5.1M | $20.3M | ||
| Q2 24 | $770.0K | $-4.5M | ||
| Q1 24 | $-1.3M | $-4.8M |
毛利率ABXPBYI
| Q4 25 | 88.8% | 69.3% | ||
| Q3 25 | 87.8% | 77.7% | ||
| Q2 25 | 89.2% | 76.5% | ||
| Q1 25 | 83.9% | 77.1% | ||
| Q4 24 | 88.8% | 76.4% | ||
| Q3 24 | 92.2% | 63.9% | ||
| Q2 24 | 90.6% | 77.4% | ||
| Q1 24 | 87.3% | 75.5% |
营业利润率ABXPBYI
| Q4 25 | 31.7% | 22.7% | ||
| Q3 25 | 35.6% | 17.6% | ||
| Q2 25 | 40.1% | 12.7% | ||
| Q1 25 | 47.6% | 8.7% | ||
| Q4 24 | -50.5% | 22.6% | ||
| Q3 24 | 24.3% | 27.4% | ||
| Q2 24 | 23.3% | -4.6% | ||
| Q1 24 | 10.5% | -5.3% |
净利率ABXPBYI
| Q4 25 | 10.1% | — | ||
| Q3 25 | 11.2% | 16.2% | ||
| Q2 25 | 31.3% | 11.2% | ||
| Q1 25 | 10.5% | 6.5% | ||
| Q4 24 | -55.0% | — | ||
| Q3 24 | -18.2% | 25.2% | ||
| Q2 24 | 2.6% | -9.6% | ||
| Q1 24 | -6.3% | -11.0% |
每股收益（稀释后）ABXPBYI
| Q4 25 | $0.06 | $0.26 | ||
| Q3 25 | $0.07 | $0.17 | ||
| Q2 25 | $0.18 | $0.12 | ||
| Q1 25 | $0.05 | $0.06 | ||
| Q4 24 | $-0.26 | $0.40 | ||
| Q3 24 | $-0.07 | $0.41 | ||
| Q2 24 | $0.01 | $-0.09 | ||
| Q1 24 | $-0.02 | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $38.1M | $97.5M |
| 总债务越低越好 | $405.8M | $22.7M |
| 股东权益账面价值 | $418.5M | $130.3M |
| 总资产 | $902.2M | $216.3M |
| 负债/权益比越低杠杆越低 | 0.97× | 0.17× |
8季度趋势，按日历期对齐
现金及短期投资ABXPBYI
| Q4 25 | $38.1M | $97.5M | ||
| Q3 25 | $86.4M | $94.4M | ||
| Q2 25 | $74.8M | $96.0M | ||
| Q1 25 | $43.8M | $93.2M | ||
| Q4 24 | $131.9M | $101.0M | ||
| Q3 24 | $19.4M | $96.7M | ||
| Q2 24 | $91.3M | $96.8M | ||
| Q1 24 | $65.4M | $107.2M |
总债务ABXPBYI
| Q4 25 | $405.8M | $22.7M | ||
| Q3 25 | $409.3M | $34.0M | ||
| Q2 25 | — | $45.3M | ||
| Q1 25 | — | $56.7M | ||
| Q4 24 | $380.8M | $68.0M | ||
| Q3 24 | — | $79.3M | ||
| Q2 24 | — | $90.7M | ||
| Q1 24 | — | $102.0M |
股东权益ABXPBYI
| Q4 25 | $418.5M | $130.3M | ||
| Q3 25 | $434.6M | $115.3M | ||
| Q2 25 | $416.5M | $104.7M | ||
| Q1 25 | $430.6M | $97.1M | ||
| Q4 24 | $423.3M | $92.1M | ||
| Q3 24 | $257.9M | $71.1M | ||
| Q2 24 | $256.8M | $48.5M | ||
| Q1 24 | $165.3M | $51.0M |
总资产ABXPBYI
| Q4 25 | $902.2M | $216.3M | ||
| Q3 25 | $918.9M | $202.9M | ||
| Q2 25 | $848.4M | $194.9M | ||
| Q1 25 | $856.5M | $196.2M | ||
| Q4 24 | $874.2M | $213.3M | ||
| Q3 24 | $477.3M | $220.7M | ||
| Q2 24 | $483.9M | $205.0M | ||
| Q1 24 | $376.7M | $214.1M |
负债/权益比ABXPBYI
| Q4 25 | 0.97× | 0.17× | ||
| Q3 25 | 0.94× | 0.30× | ||
| Q2 25 | — | 0.43× | ||
| Q1 25 | — | 0.58× | ||
| Q4 24 | 0.90× | 0.74× | ||
| Q3 24 | — | 1.12× | ||
| Q2 24 | — | 1.87× | ||
| Q1 24 | — | 2.00× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-25.7M | $14.4M |
| 自由现金流经营现金流 - 资本支出 | $-26.6M | $14.4M |
| 自由现金流率自由现金流/营收 | -37.0% | 19.1% |
| 资本支出强度资本支出/营收 | 1.3% | 0.0% |
| 现金转化率经营现金流/净利润 | -3.55× | — |
| 过去12个月自由现金流最近4个季度 | $-45.7M | $41.7M |
8季度趋势，按日历期对齐
经营现金流ABXPBYI
| Q4 25 | $-25.7M | $14.4M | ||
| Q3 25 | $-32.8M | $9.7M | ||
| Q2 25 | $76.1M | $14.1M | ||
| Q1 25 | $-61.6M | $3.6M | ||
| Q4 24 | $-208.8M | $15.6M | ||
| Q3 24 | $-52.3M | $11.0M | ||
| Q2 24 | $-67.1M | $1.0M | ||
| Q1 24 | $2.5M | $11.2M |
自由现金流ABXPBYI
| Q4 25 | $-26.6M | $14.4M | ||
| Q3 25 | $-32.9M | $9.7M | ||
| Q2 25 | $75.7M | $14.1M | ||
| Q1 25 | $-61.8M | $3.6M | ||
| Q4 24 | $-209.6M | $15.6M | ||
| Q3 24 | $-52.5M | $11.0M | ||
| Q2 24 | $-67.2M | $1.0M | ||
| Q1 24 | $2.4M | — |
自由现金流率ABXPBYI
| Q4 25 | -37.0% | 19.1% | ||
| Q3 25 | -52.3% | 17.7% | ||
| Q2 25 | 134.6% | 26.8% | ||
| Q1 25 | -140.0% | 7.7% | ||
| Q4 24 | -631.1% | 26.4% | ||
| Q3 24 | -186.6% | 13.7% | ||
| Q2 24 | -231.3% | 2.1% | ||
| Q1 24 | 10.9% | — |
资本支出强度ABXPBYI
| Q4 25 | 1.3% | 0.0% | ||
| Q3 25 | 0.3% | 0.0% | ||
| Q2 25 | 0.8% | 0.0% | ||
| Q1 25 | 0.5% | 0.1% | ||
| Q4 24 | 2.4% | 0.0% | ||
| Q3 24 | 0.9% | 0.0% | ||
| Q2 24 | 0.7% | 0.0% | ||
| Q1 24 | 0.8% | 0.0% |
现金转化率ABXPBYI
| Q4 25 | -3.55× | — | ||
| Q3 25 | -4.63× | 1.10× | ||
| Q2 25 | 4.33× | 2.41× | ||
| Q1 25 | -13.28× | 1.21× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.54× | ||
| Q2 24 | -87.09× | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ABX
| Life Solutions Segment | $63.0M | 88% |
| Asset Management Segment | $8.7M | 12% |
PBYI
暂无分部数据
